GlassScriptPhysician profile
Samir Tomajian
NPI 1275705949
$4,802.49
in general payments reported to CMS, 2019-2025
33 companies · $638 in 2025
The $638 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,727 · 2020: $117 · 2021: $213 · 2022: $434 · 2023: $793 · 2024: $880 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,311.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,172.36 | 2019 | |
| Abbvie INC. | $937.81 | 2022-2025 | Botox |
| Boston Scientific Corporation | $896.78 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $481.97 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Si-Bone, INC. | $135.65 | 2021-2025 | |
| Abbott Laboratories | $127.27 | 2020-2023 | Proclaim |
| E.R. Squibb & Sons, L.L.C. | $116.15 | 2019 | |
| Merck Sharp & Dohme LLC | $87.21 | 2019-2025 | Bridion |
| Collegium Pharmaceutical, INC. | $81.15 | 2023-2024 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.27 | 2022-2024 | Relistor |
| Vertex Pharmaceuticals Incorporated | $78.11 | 2024-2025 | |
| Allergan, INC. | $77.56 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $72.85 | 2022-2024 | Xeomin |
| Biotronik Nro, INC. | $50.45 | 2025 | Prospera |
| Spr Therapeutics, INC | $47.11 | 2025 | Sprint Pns System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $44.52 | 2019 | |
| Medtronic USA, INC. | $28.47 | 2019-2020 | |
| Averitas Pharma INC. | $25.94 | 2025 | Qutenza |
| Djo, LLC | $25.69 | 2019 | |
| Relievant Medsystems, INC. | $24.56 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.45 | 2025 | Zilretta |
| Sanofi-Aventis U.S. LLC | $24.00 | 2019 | |
| Spinal Simplicity, LLC | $19.23 | 2023 | Ha Minuteman G3-R |
| Globus Medical, INC. | $18.28 | 2025 | Vyrsa V1 |
| Forte Bio-Pharma LLC | $16.73 | 2023 | Prolate, Nalocet |
| Biohaven Pharmaceuticals, INC. | $16.21 | 2021 | |
| Valinor Pharma, LLC | $16.16 | 2023 | Movantik |
| Nevro Corp. | $15.57 | 2019 | |
| Fujifilm Sonosite, INC. | $14.18 | 2019 | |
| Ambu INC. | $13.75 | 2025 | |
| Flowonix Medical Incorporated | $12.54 | 2020 | |
| Mallinckrodt Enterprises LLC | $12.27 | 2019 | |
| Epimed International, INC | $7.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Tomajian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.